Detalhe da pesquisa
1.
Antibody effector functions are associated with protection from respiratory syncytial virus.
Cell
; 185(26): 4873-4886.e10, 2022 12 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36513064
2.
Safety, Immunogenicity, and Regimen Selection of Ad26.RSV.preF-Based Vaccine Combinations: A Randomized, Double-blind, Placebo-Controlled, Phase 1/2a Study.
J Infect Dis
; 229(1): 19-29, 2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433021
3.
Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine.
J Virol
; 97(11): e0077123, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37902399
4.
Concomitant Administration of Ad26.RSV.preF/RSV preF Protein Vaccine and High-dose Influenza Vaccine in Adults 65 Years and Older: a Noninferiority Trial.
J Infect Dis
; 2023 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38134393
5.
Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18-50 Years and RSV-Seropositive Children 12-24 Months.
J Infect Dis
; 227(1): 71-82, 2022 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36259542
6.
Phase 1 Safety and Immunogenicity Study of a Respiratory Syncytial Virus Vaccine With an Adenovirus 26 Vector Encoding Prefusion F (Ad26.RSV.preF) in Adults Aged ≥60 Years.
J Infect Dis
; 222(6): 979-988, 2020 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32320465
7.
Interactions of peptide triazole thiols with Env gp120 induce irreversible breakdown and inactivation of HIV-1 virions.
Retrovirology
; 10: 153, 2013 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24330857
8.
RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models.
Vaccines (Basel)
; 11(3)2023 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36992257
9.
T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults.
Front Immunol
; 14: 1260146, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37936699
10.
Targeting cell surface HIV-1 Env protein to suppress infectious virus formation.
Virus Res
; 235: 33-36, 2017 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28390972
11.
Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16.
Mucosal Immunol
; 9(6): 1549-1558, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26960182